Inside the Lab Industry: COVID-19 Declines Kill Top Lab Company Earnings but Genetic Firms Rebound
Yet, despite these declines, Q1 was neither as bad as expected nor totally devoid of positive signs for the future.
Yet, despite these declines, Q1 was neither as bad as expected nor totally devoid of positive signs for the future.
The wave of layoffs, which began last year with the declines in COVID-19 testing sales, has gathered momentum in 2023.
Our June virtual event will offer a variety of solutions and strategies for dealing with key issues labs face during times of economic strife.
On Friday, the US federal trade commission ordered Illumina to divest Grail, which it acquired for $8 billion in August 2021.
A recently released report estimates that the US market will grow at a CAGR of 4.2 percent over the next seven years.